Step-brothers in arms, SAGA and ATAC co-activator complexes, use different strategies.
- Open access
SAGA and ATAC co-activator complexes use distinct strategies to regulate gene transcription, with implications for cancer therapy.
- Why it matters: Understanding how these complexes differ is crucial because their dysregulation can lead to cancer progression, highlighting the need for targeted treatments.
- What they did: The review synthesizes emerging evidence on their differential interactions with transcription factors, chromatin recognition, and roles in gene regulation, emphasizing their unique and shared functions.
- The result: Insights into their distinct mechanisms enable the development of small-molecule inhibitors, offering promising avenues for precision oncology interventions.